Jasmin Tiro is a Professor in the Department of Public Health Sciences and Associate Director of Cancer Prevention and Population Science for the University of Chicago Medicine Comprehensive Cancer Center. She is a behavioral scientist focused in cancer care delivery research. Her program of research identifies multi-level determinants of cancer prevention and early detection behaviors (e.g., HPV vaccination; breast, cervical, and colorectal cancer screening; hepatocellular cancer surveillance) and uses quantitative and qualitative (mixed) methods to develop, test, and implement interventions. The availability of screening tests to detect breast, cervical, and colorectal cancer early and the HPV vaccine to prevent HPV-related cancers are great public health accomplishments; however, there are segments of the population that still do not receive the full benefits of these behaviors. All of these health behaviors require individuals to interact with health care provider teams and systems. Effective interventions must take into account the local community and policy context and must be easy to implement and sustain. Further, as new technologies (e.g., home-based HPV self-screening) prove effective and are incorporated into clinical guidelines, the need for appropriate and effective communications to transfer knowledge from “bench to bedside” will be even greater in order to maximize the potential of these new technologies in reducing cancer morbidity and mortality. Dr. Tiro's research is at the interface of intervention and implementation science, requires engagement of diverse communities, and is dedicated to promoting equity in cancer outcomes.
University of Texas School of Public Health
Houston, Texas
PhD - Behavioral Sciences
2005
Emory University- Rollins School of Public Health
Atlanta, Georgia
MPH - Behavioral Sciences & Health Education
1999
Rice University
Houston, Texas
BA - Biochemistry
1997
Gaps in care across the cancer screening continuum for cervical, colorectal, and lung cancers.
Gaps in care across the cancer screening continuum for cervical, colorectal, and lung cancers. J Natl Cancer Inst. 2025 Dec 01; 117(12):2556-2570.
PMID: 40929058
Process Mapping to Compare and Improve Management of Abnormal Cervical Cancer Screening Results in Two US Healthcare Systems within the PROSPR Consortium.
Process Mapping to Compare and Improve Management of Abnormal Cervical Cancer Screening Results in Two US Healthcare Systems within the PROSPR Consortium. Cancer Epidemiol Biomarkers Prev. 2025 Nov 03; 34(11):1989-1999.
PMID: 40879504
Improving Communication and Management Following a Positive Home HPV Self-Sampling Result: Comparing Intervention Strategies Between the HOME and STEP Trials.
Improving Communication and Management Following a Positive Home HPV Self-Sampling Result: Comparing Intervention Strategies Between the HOME and STEP Trials. Womens Health Rep (New Rochelle). 2025; 6(1):771-781.
PMID: 40927032
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management Guidelines.
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management Guidelines. J Gen Intern Med. 2026 Feb; 41(3):759-766.
PMID: 40445578
Inpatient Adolescent Sexual Health Services and Long-Acting Reversible Contraception Training.
Inpatient Adolescent Sexual Health Services and Long-Acting Reversible Contraception Training. Hosp Pediatr. 2025 Apr 01; 15(4):325-333.
PMID: 40112885
Guideline-Concordant Surveillance After Treatment for High-Grade Cervical Dysplasia.
Guideline-Concordant Surveillance After Treatment for High-Grade Cervical Dysplasia. Obstet Gynecol. 2025 May 01; 145(5):461-468.
PMID: 40048731
Exploring residents' and fellows' confidence in sexually transmitted infection management and confidential care for adolescents.
Exploring residents' and fellows' confidence in sexually transmitted infection management and confidential care for adolescents. Sex Health. 2025 02; 22.
PMID: 39946224
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings.
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings. JAMA Netw Open. 2025 01 02; 8(1):e2454969.
PMID: 39821397
Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019.
Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019. Cancer Causes Control. 2025 Mar; 36(3):275-284.
PMID: 39537980
Exploring adolescent contraceptive counseling: A hypothetical daughter scenario.
Exploring adolescent contraceptive counseling: A hypothetical daughter scenario. Patient Educ Couns. 2025 Jan; 130:108486.
PMID: 39504803
Bill Aston Award for Quality
Texas Hospital Association
2017
Outstanding Mentorship Award
University of Texas Southwestern, Center for Translational Medicine
2014
Cancer Prevention Research Training Merit Award
National Cancer Institute
2007
Fellows Award for Research Excellence
National Institutes of Health
2006
AACR/ACS Scholarship for Behavioral Scientists
American Association for Cancer Research & American Cancer Society
2006
Dr. Ronald Lorimor Scholarship
University of Texas
2004
Dr. Lawrence E. Lamb Scholarship
University of Texas
2002
Delta Omega National Public Health Honor Society
Emory Rollins School of Public Health
1999